This process may cause an energy deficit in some individuals, which could contribute to feelings of tiredness
Understanding Ozempic (semaglutide) Eli Lillys brand name drug Ozempic, also known as semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been approved for the treatment of both type 2 diabetes and obesity
GLP-1RAs reduce risks of neurocognitive, substance use, cardiovascular and respiratory disorders, but increase risks of gastrointestinal issues, hypotension and pancreatitis
"Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants." Clinical Therapeutics
Yet gut-safe is not the same as risk-free
Patients with specific genetic variants may metabolize certain drugs differently or experience heightened sensitivity to particular side effects, allowing your clinician to preemptively avoid problematic medication combinations